Antiplatelet and vascular effects of aspirin in healthy persons and patients with type 2 diabetes

Background: Treatment with aspirin is a cornerstone in the secondary prevention of cardiovascular disease (CVD) in diabetes, whereas its place in primary prevention remains controversial.

Source: Artery Research - November 25, 2016 Category: Cardiology Authors: Liv Vernstroem Hald, Anne-Mette Hvas, Erik Lerkevang Grove, Esben Laugesen, Kristian Loekke Funck, Per Loegstrup Poulsen Source Type: research